Replies to post #295337 on Anavex Life Sciences Corp (AVXL)

[RedShoulder]

AVXL is still under the radar for most bio investors.

That may change soon.

[Jimbo50]

Retail own most of avxl. They sell every 10 cents. SAVA owned by institutions and they add to their own holdings driving up the price.

[Simonizer]

SAVA now about 5 times our MC.

[CogDiss 1188X]

I believe I can explain it the difference in market cap. SAVA just published data that shows it not only slows cognitive decline but actually improves it (however slightly). Apparently, no drug has done that in the past.

Admittedly it is still very early data but their prior 28 day study also showed nice improvement across a wide range of biomarkers. Pretty good results in just 28 days of treatment.

AVXL has shown promise against Alzheimer’s but from what I remember it was a subgroup of 5 or so patients who received a higher dose. I had to read between the lines closely as I remember. Promising to be sure but not as much evidence of efficacy as SAVA has at this point.

BTW, I own both AVXL and SAVA.